Uncategorized
VEGF Trap-Eye improves vision in diabetic eye disease
NEW YORK (Reuters Health) -Vascular Endothelial Growth Factor (VEGF) Trap-Eye provided a significant
benefit to patients with diabetic macular edema in a phase II trial - and updated data now shows the initial
improvements were sustained or increased a year later.